Literature DB >> 21839172

Molecular dynamics simulations of human DNA methyltransferase 3B with selective inhibitor nanaomycin A.

Thomas Caulfield1, José L Medina-Franco.   

Abstract

DNA methyltransferases (DNMTs) are involved in epigenetic regulation of the genome and are promising targets for therapeutic intervention in cancer and other diseases. Until now, very limited information is available concerning the molecular dynamics of DNMTs. The natural product nanaomycin A is the first selective inhibitor of DNMT3B that induce genomic demethylation. Herein we report long (>100ns) molecular dynamics simulations for human DNMT3B bound to nanaomycin A with and without the presence of the cofactor S-adenosyl-L-methionine (SAM). We concluded that SAM favors the binding of nanaomycin A to DNMT3B. Key interactions of nanaomycin A with DNMT3B involve long lasting interactions with Arg731, Arg733, Arg832, and the catalytic Cys651. Results further support the previous hypothesis that nanaomycin A has key interactions with amino acid residues involved in the mechanism of methylation. This work represents one of the first molecular dynamics studies of DNMT3B. Results of this work shed light on the structure and binding recognition process of a key epigenetic enzyme with a small molecule inhibitor.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21839172     DOI: 10.1016/j.jsb.2011.07.015

Source DB:  PubMed          Journal:  J Struct Biol        ISSN: 1047-8477            Impact factor:   2.867


  34 in total

1.  Structural and Functional Impact of Parkinson Disease-Associated Mutations in the E3 Ubiquitin Ligase Parkin.

Authors:  Fabienne C Fiesel; Thomas R Caulfield; Elisabeth L Moussaud-Lamodière; Kotaro Ogaki; Daniel F A R Dourado; Samuel C Flores; Owen A Ross; Wolfdieter Springer
Journal:  Hum Mutat       Date:  2015-06-03       Impact factor: 4.878

2.  Long-range electrostatic complementarity governs substrate recognition by human chymotrypsin C, a key regulator of digestive enzyme activation.

Authors:  Jyotica Batra; András Szabó; Thomas R Caulfield; Alexei S Soares; Miklós Sahin-Tóth; Evette S Radisky
Journal:  J Biol Chem       Date:  2013-02-19       Impact factor: 5.157

3.  An Acrobatic Substrate Metamorphosis Reveals a Requirement for Substrate Conformational Dynamics in Trypsin Proteolysis.

Authors:  Olumide Kayode; Ruiying Wang; Devon F Pendlebury; Itay Cohen; Rachel D Henin; Alexandra Hockla; Alexei S Soares; Niv Papo; Thomas R Caulfield; Evette S Radisky
Journal:  J Biol Chem       Date:  2016-11-03       Impact factor: 5.157

4.  Synthesis and evaluation of derivatives of the proteasome deubiquitinase inhibitor b-AP15.

Authors:  Xin Wang; Pádraig D'Arcy; Thomas R Caulfield; Aneel Paulus; Kasyapa Chitta; Chitralekha Mohanty; Joachim Gullbo; Asher Chanan-Khan; Stig Linder
Journal:  Chem Biol Drug Des       Date:  2015-05-27       Impact factor: 2.817

5.  Molecular Inhibitor of QSOX1 Suppresses Tumor Growth In Vivo.

Authors:  Amber L Fifield; Paul D Hanavan; Douglas O Faigel; Eduard Sergienko; Andrey Bobkov; Nathalie Meurice; Joachim L Petit; Alysia Polito; Thomas R Caulfield; Erik P Castle; John A Copland; Debabrata Mukhopadhyay; Krishnendu Pal; Shamit K Dutta; Huijun Luo; Thai H Ho; Douglas F Lake
Journal:  Mol Cancer Ther       Date:  2019-10-01       Impact factor: 6.261

6.  Structure-Guided Identification of DNMT3B Inhibitors.

Authors:  Ana S Newton; John C Faver; Goran Micevic; Viswanathan Muthusamy; Shalley N Kudalkar; Nicole Bertoletti; Karen S Anderson; Marcus W Bosenberg; William L Jorgensen
Journal:  ACS Med Chem Lett       Date:  2020-02-07       Impact factor: 4.345

7.  Targeted inhibition of the deubiquitinating enzymes, USP14 and UCHL5, induces proteotoxic stress and apoptosis in Waldenström macroglobulinaemia tumour cells.

Authors:  Kasyapa Chitta; Aneel Paulus; Sharoon Akhtar; Maja Kristin K Blake; Thomas R Caulfield; Anne J Novak; Stephen M Ansell; Pooja Advani; Sikander Ailawadhi; Taimur Sher; Stig Linder; Asher Chanan-Khan
Journal:  Br J Haematol       Date:  2015-02-17       Impact factor: 6.998

Review 8.  A chemical probe toolbox for dissecting the cancer epigenome.

Authors:  Jake Shortt; Christopher J Ott; Ricky W Johnstone; James E Bradner
Journal:  Nat Rev Cancer       Date:  2017-02-23       Impact factor: 60.716

9.  Disulfide engineering of human Kunitz-type serine protease inhibitors enhances proteolytic stability and target affinity toward mesotrypsin.

Authors:  Itay Cohen; Matt Coban; Anat Shahar; Banumathi Sankaran; Alexandra Hockla; Shiran Lacham; Thomas R Caulfield; Evette S Radisky; Niv Papo
Journal:  J Biol Chem       Date:  2019-01-30       Impact factor: 5.157

10.  Attacking COVID-19 Progression Using Multi-Drug Therapy for Synergetic Target Engagement.

Authors:  Mathew A Coban; Juliet Morrison; Sushila Maharjan; David Hyram Hernandez Medina; Wanlu Li; Yu Shrike Zhang; William D Freeman; Evette S Radisky; Karine G Le Roch; Carla M Weisend; Hideki Ebihara; Thomas R Caulfield
Journal:  Biomolecules       Date:  2021-05-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.